Skip to main content

Animations

MJFF Publications

41 - 50 of 8587 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2018
  • 2021
  • 2017
  • 2015
  • 2014
  • 2011
  • 2023
  • 2023
  • Summary Details
    RESTRICTED
    Title: Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinic
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/nmt-2021-0055
    Best OA location URL:
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Infection and Risk of Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: IOS Press
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-202279
    Citation Count: 70
  • Summary Details
    RESTRICTED
    Title: Toward defining deep brain stimulation targets in MNI space: A subcortical atlas based on multimodal MRI, histology and structural connectivity
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.05.015
    Citation Count: 428
  • Summary Details
    RESTRICTED
    Title: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868
    Citation Count: 68
  • Summary Details
    RESTRICTED
    Title: Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2017.09.055
    Citation Count: 388
  • Summary Details
    RESTRICTED
    Title: The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.049
    Citation Count: 111
  • Summary Details
    RESTRICTED
    Title: Therapy for Parkinson’s Disease: What is in the Pipeline?
    Journal Name: Neurotherapeutics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-013-0242-1
    Citation Count: 20
  • Summary Details
    RESTRICTED
    Title: Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2011.05.019
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Perspective on the current state of the LRRK2 field
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00544-7
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00535-8
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.